Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics
Paxton, J.W.
New Zealand Medical Journal 94(697): 423-425
1981
ISSN/ISBN: 0028-8446 PMID: 6977751 Document Number: 180889
Document emailed within 1 workday
Related Documents
Okazaki, M.; Eto, K.; Furuno, K.; Oishi, R.; Gomita, Y. 1995: Influences of immobilization and footshock stress on pharmacokinetics of theophylline and caffeine in rats Journal of Pharmacy and Pharmacology 47(6): 530-533Hiernaux, J. 1970: Environmental and genetic influences upon growth Journal of Anatomy 107(Part 1): 181-182
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Haus, M.; Heese, H.D.; Weinberg, E.G.; Potter, P.C.; Malherbe, D.; Hall, J.M. 1990: Genetic and environmental influences on cord blood serum IgE and on atopic sensitisation in infancy South African Medical Journal 77(1): 7-13
Verweij, K.J.H.; Zietsch, B.P.; Bailey, J.M.; Martin, N.G. 2009: Shared aetiology of risky sexual behaviour and adolescent misconduct: genetic and environmental influences Genes Brain and Behavior 8(1): 107-113
1979: Significance of pharmacokinetics for the therapeutic practice Casopis Lekaru Ceskych 118(4): 126-127
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Qiu, H.; Zhuang, W.; Wang, X.; Huang, M.; Zhou, Z. 2017: Association between genetic polymorphisms and variation of imatinib pharmacokinetics in gastrointestinal stromal tumors Zhonghua Wei Chang Wai Ke Za Zhi 20(9): 1031-1034
Zheng, T.; Su, C.H.; Zhao, J.; Zhang, X.J.; Zhang, T.Y.; Zhang, L.R.; Kan, Q.C.; Zhang, S.J. 2013: Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects Die Pharmazie 68(4): 257-260
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Levy, G. 1978: Clinical pharmacokinetics of aspirin Pediatrics 62(5 Pt 2(Suppl): 867-872
Boĭko, S.S.; Zherdev, V.P.; Kisliak, N.A. 1991: The clinical pharmacokinetics of kemantane Farmakologiia i Toksikologiia 54(1): 57-59
Serov, N.V.; Treskov, V.G.; Berliand, A.S.; Knizhnik, A.Z.; Lapin, K.V. 1984: Clinical pharmacokinetics of mebikar Farmakologiia i Toksikologiia 47(3): 94-97
Olson, S.C.; Horvath, A.M.; Michniewicz, B.M.; Sedman, A.J.; Colburn, W.A.; Welling, P.G. 1989: The clinical pharmacokinetics of quinapril Angiology 40(4 Pt 2): 351-359
Fauvelle, F.; Petitjean, O.; Tod, M.; Guillevin, L. 2000: Clinical pharmacokinetics during plasma exchange Therapie 55(2): 269-275
Clara, L.O.; Biglia, M.A. 1999: Pharmacokinetics of trovafloxacin: its clinical significance Medicina 59(Suppl): 17-22
Mäntylä, R.; Kanto, J. 1981: Clinical pharmacokinetics of methylergometrine (methylergonovine) International Journal of Clinical Pharmacology Therapy and Toxicology 19(9): 386-391
Platt, D.; Mühlberg, W.; Rieck, W. 1985: The effect of age on clinical pharmacokinetics of piracetam Arzneimittel-Forschung 35(2): 533-535